[ad_1]
On Friday morning Norwegian time, the president of the United States, Donald Trump, was confirmed to be infected with the coronavirus.
On Friday night Norwegian time, his doctor writes in a press release that the president is receiving the experimental drug Regeneron, which will help with the disease.
The drug has not been approved and there is still a long way to go before it can be, Director John Arne Røttingen at the Dagbladet Research Council said Friday night.
President Trump is exhausted, but in a good mood, according to his doctor.
see more
Experimental
The drug is an antiviral drug that aims to reduce the effects of the coronavirus.
– This is one of the new drugs that we are waiting to be better evaluated, says Røttingen.
He says it is a so-called monoclonal antibody, which aims to mimic the antibodies that the body itself produces to fight disease, thereby lowering the level of the virus, reducing symptoms, and shortening the period of illness.
– The president is exhausted
Røttingen explains that it is developed by extracting antibodies from people who have had the disease and developed particularly neutralizing antibodies, and reproduces them synthetically.
The drug that Trump is receiving now is a mixture of two different antibodies.
Limited study
Regeneron recently wrote in a press release that they believe the drug works. The study itself is based on trials of 275 patients and has yet to be published. Therefore, the study has not yet been peer-reviewed. This means that the study has not yet been recognized and confirmed by other researchers.
– This indicates that it is a promising drug and that it reduces the level of virus, but currently the results are too unclear to give any kind of approval, Røttingen tells Dagbladet.
Mock Infection Control – Got infected
He says that since this is an experimental treatment. Therefore, Trump is entitled to all information about the risks associated with the drug.
Røttingen says that Regeneron’s data shows that two people have had serious side effects during the testing phase, but emphasizes that it is not known whether it is due to the drug or the disease.
